PILERI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 6.844
NA - Nord America 5.921
EU - Europa 3.760
AF - Africa 427
SA - Sud America 317
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.292
Nazione #
US - Stati Uniti d'America 5.804
VN - Vietnam 2.215
SG - Singapore 1.718
CN - Cina 1.509
IT - Italia 788
GB - Regno Unito 742
HK - Hong Kong 536
DE - Germania 486
SE - Svezia 472
IN - India 286
FR - Francia 252
BR - Brasile 212
RU - Federazione Russa 204
ZA - Sudafrica 179
KR - Corea 155
IE - Irlanda 134
UA - Ucraina 129
NL - Olanda 122
CI - Costa d'Avorio 94
JP - Giappone 93
FI - Finlandia 77
BG - Bulgaria 72
CA - Canada 62
TG - Togo 54
CH - Svizzera 51
EE - Estonia 50
AR - Argentina 44
ID - Indonesia 39
PH - Filippine 39
MX - Messico 38
AT - Austria 34
BD - Bangladesh 32
TR - Turchia 32
PL - Polonia 30
SC - Seychelles 29
JO - Giordania 27
TH - Thailandia 27
ES - Italia 26
NG - Nigeria 26
AU - Australia 19
IR - Iran 18
TW - Taiwan 18
EC - Ecuador 17
IQ - Iraq 15
UZ - Uzbekistan 15
SA - Arabia Saudita 14
CO - Colombia 13
BE - Belgio 12
CL - Cile 12
HR - Croazia 12
EG - Egitto 11
LT - Lituania 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 9
LB - Libano 7
DK - Danimarca 6
PT - Portogallo 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
CZ - Repubblica Ceca 5
GR - Grecia 5
MD - Moldavia 5
PY - Paraguay 5
RS - Serbia 5
VE - Venezuela 5
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
MY - Malesia 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
JM - Giamaica 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
KE - Kenya 2
MM - Myanmar 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AO - Angola 1
AW - Aruba 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
ET - Etiopia 1
Totale 17.272
Città #
Singapore 1.163
Southend 619
Ashburn 592
Ho Chi Minh City 551
Fairfield 548
Hong Kong 504
Hanoi 458
Chandler 450
San Jose 436
Hefei 325
Santa Clara 278
Houston 221
Beijing 220
Woodbridge 219
Seattle 218
Wilmington 218
Princeton 185
Bologna 166
Cambridge 158
Dong Ket 140
Dublin 134
Seoul 134
Boardman 125
Johannesburg 115
Ann Arbor 102
New York 98
Los Angeles 97
Abidjan 94
Lauterbourg 94
Dallas 81
Tokyo 75
Da Nang 72
Haiphong 66
Nanjing 65
Sofia 65
Westminster 65
Jacksonville 60
Redmond 56
Helsinki 55
Berlin 54
Lomé 54
Redondo Beach 50
Milan 48
Buffalo 44
Padova 43
Saint Petersburg 41
Bremen 39
Council Bluffs 39
Frankfurt am Main 39
Jinan 39
San Diego 38
London 35
Turin 34
Munich 32
Rome 31
Redwood City 30
Shenyang 30
São Paulo 30
Bengaluru 28
Thái Nguyên 28
Amman 27
Can Tho 27
Changsha 27
Quận Bình Thạnh 27
Vienna 27
Abeokuta 25
Bern 25
Chicago 25
Tianjin 25
Hải Dương 24
Ha Long 23
Biên Hòa 22
Hangzhou 22
Hebei 22
Jakarta 22
Shanghai 22
Zhengzhou 22
Guangzhou 21
Nanchang 21
Vũng Tàu 21
Warsaw 21
San Francisco 20
Bangkok 19
Falls Church 19
Florence 18
Phoenix 18
Delhi 17
Des Moines 17
Mülheim 17
Bắc Ninh 16
Norwalk 16
Nuremberg 16
Orem 16
Quận Sáu 16
Bắc Giang 15
Ninh Bình 15
Olalla 15
Verona 15
Yubileyny 15
Dearborn 14
Totale 10.940
Nome #
Merkel cell carcinoma: a prompt diagnosis to increase survival 659
Napkin psoriasis and the risk of later psoriasis development: A single-centre retrospective study 349
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 266
Management of malignant cutaneous wounds in oncologic patients 254
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine 246
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 226
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 223
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 222
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 217
Herpes zoster in COVID-19-positive patients 205
Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. 202
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 194
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis 189
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 189
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 186
Atopic Dermatitis and the Atopic March: What Is New? 185
Photodynamic therapy: An option in mycosis fungoides 182
Anaplastic Large Cell Lymphoma: a critical reappraisal 180
Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma 180
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 179
Annular lesions located on the right forearm. 177
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 177
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 173
Mycosis fungoides following pityriasis lichenoides: An exceptional event or a potential evolution? 172
Atypical piloleiomyoma of the face presenting with central ulceration 172
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 169
Rosacea-like tinea incognito 166
Cutaneous adverse-events in patients treated with Ibrutinib 166
Leukemia cutis in a Ph+ ALL patient treated with ponatinib 165
Chilblain lesions after COVID-19 mRNA vaccine 164
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 161
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 161
Granulomatous tattoo reaction in a nivolumab-treated patient 159
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 156
Large granular lymphocytic leukaemia mimicking ulcer of the lower limb 155
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 155
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 152
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 152
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 152
Vemurafenib mucosal side-effect. 152
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 151
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 150
Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis: Synergistic Action or Fortuitous Coincidence? 150
An asymptomatic plaque on the chest: A quiz 147
Persistent agmination of lymphomatoid papulosis: an ongoing debate. 145
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy 144
Brownish asymptomatic lesions on the arms and legs 142
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 140
Alopecia areata-like mycosis fungoides: Lions for lambs 140
Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. 139
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 139
Papular mycosis fungoides: a new casa expanding the spectrum of phenotypic and clinical findings 138
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 138
Nb‐UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single‐center cross‐sectional study 137
The karma of Kikuchi's disease. 137
Dermatofibrosarcoma protuberans secondary to a decorative tattoo: An Isotattootopic Response? 135
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 135
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 135
Erythematous induration of the chest 133
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 133
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 131
Multiple familial trichodiscomas. 130
A large mass and erythematous-violaceous plaques - Ein großer tumor und livid-erythematöse plaques 130
Extramedullary metastatic plasmacytoma in a multiple myeloma patient 129
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients 128
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis 128
Peripheral T-cell lymphoma. 127
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? 127
Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 126
Indolent lymphoma: the pathologist's viewpoint 126
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia 125
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model 125
Lymphoma classification: Past, present and future 124
Multiple Eruptive Sebaceous Hyperplasia Secondary to Muir-Torre Syndrome Treated With Fractional Carbon Dioxide Laser Resurfacing Technique: A Case Report 123
TOX Expression in Mycosis Fungoides and Sezary Syndrome 122
Squamous cell carcinoma developed after ingenol mebutate therapy: A possible consequence of the treatment? 122
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 122
Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism 119
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 119
Lymphoma classification: the quiet after the storm. 118
The role of myeloid derived suppressor cells in mycosis fungoides 116
A rapidly growing ulcer: an atypical presentation of Merkel cell carcinoma 115
Mycosis fungoides: disease evolution of the "lion queen" revisited. 115
Folliculotropic mycosis fungoides of the face successfully treated combining CO2 laser and conventional photodynamic therapy (c-PDT) 114
Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection 114
Verrucous mycosis fungoides. 111
Erosive pustular dermatosis of the leg: An uncommon entity? 110
Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas? 108
Sézary Syndrome without erythroderma featuring a CD30+ progression 104
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 101
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 99
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum? 98
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides 98
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 98
Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient 97
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 95
Cutaneous involvement in multiple myeloma. A rare entity 93
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis 92
Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP) 89
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 87
Totale 15.352
Categoria #
all - tutte 47.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021439 0 0 0 0 0 0 0 0 0 0 50 389
2021/20221.598 83 45 99 137 148 98 27 137 88 137 337 262
2022/20231.880 208 264 107 247 140 152 69 144 265 63 154 67
2023/2024593 39 109 33 48 35 109 80 44 10 36 18 32
2024/20252.752 108 363 220 213 438 103 240 100 56 176 168 567
2025/20267.284 851 1.107 583 492 728 391 629 329 1.353 573 248 0
Totale 17.680